Patient Note — 152994
progress_notes_152994_1_deid.txt
Demographics & Encounter
Patient ID152994 (PHI redacted)
Age / Gender76 / Female
Date of Service2026-04-06
Provider[PROVIDER_NAME]
FacilityPOTOMAC UROLOGY CENTER - Alexandria
PayerHighmark Medicare
Reason1. Kidney Stone
Diagnoses
N20.0
Nephrolithiasis
R39.15
Urgency of urination
Medications
Vitamin B-12
Vitamin D3
Donepezil HCl
Atorvastatin Calcium
Memantine HCl
Trospium Chloride
Celecoxib
Estrace(Estradiol) 0.1 MG/GM Cream NO applicator, pea-sized amount at the tip of the finger Vaginal every other day
hydroCHLOROthiazide
Vitamin B12
Progress Note: [PROVIDER_NAME], MD 04/06/2026
Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com)
Generated for Printing/Faxing/eTransmitting on: 04/18/2026 12:51 PM EDT
2/5
4/18/26, 9:51 AM Print Preview
[PATIENT_NAME] DOB: [DOB] (76 yo F) Acc No. [ACCOUNT_ID] DOS: 04/06/2026
predniSONE
DAYS
Ditropan XL
Famotidine
Breo Ellipta
Medication List reviewed and reconciled with the patient
Past Medical History
- High Cholesterol
- CNT
- Bladder cancer
Vitals
RR
16.0
HR
81.0
BP
93/70
BMI
20.12
WEIGHT
110 lbs
HEIGHT_IN
62.0
Clinical Summary (HPI)
Kidney Stone: 76 year old female, with a history of ureteral stone and uterosepsis, presents for reassessment. Dr. Desai placed a left sided stent on 03/30/2026. She notes frequent urination and blood in her urine since stent placement. Bladder Cancer: Also, with history intermediate risk bladder cancer (s/p TURBT Aug 2023). +++++++++++ Cysto: Stable calcification at the dome of the bladder, consistent with previous biopsy sites (biopsied twice), with no evidence of malignancy. [11/19/2025] Cytology: Negative (Nov 2024) Bladder Bx: (1) Inflammation and calcifications (Feb 2024) Bladder biopsy: Scant papillary fragments of urothelium compatible with papillary urothelial neoplasm of low malignant potential. Calcified acellular debris. Muscularis propria is not identified (Aug 2023) Cysto (4/2023): Necrosis at prior resection sites, no tumor. Induction Mito (1-3/2023) TURBT (12/2022): LG Ta multifocal. (1) Left lateral bladder wall tumor, excision: Low grade papillary urothelial carcinoma. No invasion identified. No muscularis propria identified. (2) Left lateral bladder wall tumor, deep: muscularis propria. [03/14/2022] low grade papillary urothelial neoplasm, non invasive. no musularis propria (1/4/23) Given proximity to left UO RBUS performed and unremarkable. No hydronephrosis [3/2022] Initial Diagnosis 3/2022: LGTa. Initial Diagnosis Initial Diagnosis Yes Presenting complaint: Gross hematuria Staging Imaging: No Date of Index TURBT 03-2022 Index TURBT Pathology: LGTa AUA Ri
Raw Note (de-identified preview)
4/18/26, 9:51 AM Print Preview
[PATIENT_NAME] DOB: [DOB] (76 yo F) Acc No. [ACCOUNT_ID] DOS: 04/06/2026
[PATIENT_NAME]
76 Y old Female, DOB: [DOB]
Account: [ACCOUNT_ID]: [PHONE] [ADDRESS]-
1862
Home: [PHONE]
Guarantor: [GUARANTOR_NAME]
Insurance: Highmark Medicare
PCP: [PROVIDER_NAME] Referring: [PROVIDER_NAME]
Appointment Facility: POTOMAC UROLOGY CENTER - Alexandria
Structured Data: How did you hear about us? : Primary Care Physician; Patient's temperature : 96.7; : 11/18/2022
04/06/2026 Progress Notes: [PROVIDER_NAME], MD
Reason for Appointment
1. Kidney Stone
History of Present Illness
Kidney Stone:
76 year old female, with a history of ureteral stone and uterosepsis, presents for reassessment. Dr. Desai placed a left
sided stent on 03/30/2026. She notes frequent urination and blood in her urine since stent placement.
Bladder Cancer:
Also, with history intermediate risk bladder cancer (s/p TURBT Aug 2023).
+++++++++++
Cysto: Stable calcification at the dome of the bladder, consistent with previous biopsy sites (biopsied twice), with no evidence
of malignancy. [11/19/2025]
Cytology: Negative (Nov 2024)
Bladder Bx: (1) Inflammation and calcifications (Feb 2024)
Bladder biopsy: Scant papillary fragments of urothelium compatible with papillary urothelial neoplasm of low malignant
potential. Calcified acellular debris. Muscularis propria is not identified (Aug 2023)
Cysto (4/2023): Necrosis at prior resection sites, no tumor.
Induction Mito (1-3/2023)
TURBT (12/2022): LG Ta multifocal.
(1) Left lateral bladder wall tumor, excision: Low grade papillary urothelial carcinoma. No invasion identified. No muscularis
propria identified. (2) Left lateral bladder wall tumor, deep: muscularis propria. [03/14/2022] low grade papillary urothelial
neoplasm, non invasive. no musularis propria (1/4/23)
Given proximity to left UO RBUS performed and unremarkable. No hydronephrosis [3/2022]
Initial Diagnosis 3/2022: LGTa.
Initial Diagnosis
Initial Diagnosis Yes
Presenting complaint: Gross hematuria
Staging Imaging: No
Date of Index TURBT 03-2022
Index TURBT Pathology: LGTa
AUA Risk Stratification AUA NMIBC Low Risk
NMIBC Low Risk Features LG Solitary Ta less than 3cm
Initial Intravesical therapy No
Recurrence
Initial (First) Recurrence Yes
Date of TURBT/biopsy 12-2022
TURBT Pathology LGTa
Progress Note: [PROVIDER_NAME], MD 04/06/2026
Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com)
Generated for Printing/Faxing/eTransmitting on: 04/18/2026 12:51 PM EDT
1/5
4/18/26, 9:51 AM Print Preview
[PATIENT_NAME] DOB: [DOB] (76 yo F) Acc No. [ACCOUNT_ID] DOS: 04/06/2026
AUA Risk Stratification (based on recurrence) AUA NMIBC intermediate risk
Yes
Risk Stratification
AUA Risk Stratification intermediate risk
Intermediate Risk features Recurrence within 1 year, LG Ta,LG Ta, multifocal
Last TURBT Information
Last TURBT Date 12/15/2022
Tumor Size < 3 cm
Tumor Grade low grade
Clinical Stage Ta
Muscle in specimen? No
Tumor site multifocal tumor
Variant hist